Brazil approves emergency use of Chinese Sinovac, AstraZeneca COVID-19 vaccines


Source: chinadaily.com.cn chinadaily.com.cn

Key Topics in this News Article:

News Snapshot:

Health care workers receive a dose of the Sinovac's coronavirus disease (COVID-19) vaccine, after Brazil health regulator Anvisa approved its emergency use at Hospital das Clinicas in Sao Paulo, Brazil Jan 17, 2021. [Photo/Agencies] SAO PAULO - Brazil's Health Regulatory Agency (Anvisa) unanimously approved on Sunday the emergency use of the CoronaVac vaccine, from the Chinese laboratory Sinovac, as well as the AstraZeneca-University of Oxford vaccine against COVID-19. The decision will allow the Brazilian government to start its vaccination plan against COVID-19 with 6 million doses of the CoronaVac vaccine, developed by Sinovac in conjunction with the Butantan Institute of...